The Roswell Park Graduate Division is an academic collaboration between the Roswell Park Cancer Institute and the University at Buffalo Graduate School.
Roswell Park Cancer Institute (RPCI) was founded in 1898 by the preeminent surgeon Dr. Roswell Park. RPCI is the world's first cancer research institute and a National Cancer Institute-designated Comprehensive Cancer Center. The internationally-recognized scientists and world-class facilities at RPCI provide an outstanding training environment for graduate students. Because RPCI is a cancer research hospital, students have a wide spectrum of choices for their research focus, from the basic investigation of cancer mechanisms to translational/clinical research with direct relevance to disease treatment. Among the areas of research at RPCI are biophysics, biochemistry, immunology, genomics, cancer pathology, cancer prevention/epidemiology, molecular biology, cell biology, cancer genetics, molecular pharmacology and cancer therapeutic development.
The RPCI Graduate Division of the University at Buffalo (UB) offers five PhD programs with a combined enrollment of approximately 100 students. The average time-to-degree for students graduating since 2000 is 5.8 years, and we are implementing changes in the curriculum and the tracking of student progress that we expect will decrease this even further.
Graduates of our doctoral program are encouraged to consider the wide variety of career options available to PhD recipients. To foster professional development we instituted a regular Career Directions seminar series that involves speakers from diverse career sectors, such as pharma/biotech, intellectual property and science policy. The series also includes workshops on job searching, interviewing, using social media and other critical skills.
Applicants are recruited from undergraduate science programs in the U.S.A. and from around the world. Each year, approximately 20 doctoral and 15 MS students are selected to study at RPCI from a highly competitive pool of applicants. In general, applicants are interested in pursuing a career in cancer or basic and translational biomedical research. Applicants admitted to our graduate programs in 2013 had an average undergraduate GPA of 3.4 and average general GRE scores in the 70th percentile. All international applicants must submit results of either the TOEFL (minimum acceptable score: 79) or the IELTS (minimum acceptable score 6.5 overall with no individual sub-score below 6.0).
Students applying to any of our PhD programs may indicate in the application if they also wish to be considered for admission by up to TWO additional programs. This eliminates the need to prepare (and pay for) multiple applications if you have interest in more than one PhD program at RPCI.
Please have GRE and TOEFL scores sent to the University at Buffalo using ETS code 2925. No department code is required.
The application deadline for fall 2016 admission has passed. Students wishing to have applications considered after the application deadline must contact the director of individual programs.
Information set forth herein is provided without warranty or guaranty as to completeness, accuracy or currency. By using the information contained herein, the viewer affirmatively assumes all risks. The author has made every effort to provide accurate, up-to-date information, and is not responsible for informational errors, omissions, nor liable for any damages resulting from the viewer's use of, or reliance upon, the material.